This negative result could be attributed either to a difference in cellular surface expression of FAT1 between human and mouse cancer cells or to the inability of mAb198.3 to bind mD8-FAT1 due to the four amino acid difference present in the D8-FAT1 sequences of the two species. The gene discussed is FAT1; the disease is cancer.